BioSpace News Archive

Pharm Country

InventHelp Inventor Develops Wearable Wellness Monitor (LCC-3748)

As a result she developed the CareBit, CareBit Plus to monitor the care and track the activity of a loved one in a hospital, rehabilitation facility or nursing home.

June 4, 2018
·
1 min read
Genetown

Genome Canada launches national initiative to bring precision health to patients

Genome Canada launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step.

June 4, 2018
·
3 min read
Biotech Bay

Doctors Call for Overhaul of Electronic Health Records

New research by Stanford Medicine, conducted by The Harris Poll, has found that American physicians want substantial improvements in the way electronic health records (EHRs) work.

June 4, 2018
·
6 min read
FDA

Micronics PanNAT STEC Test and System Receive FDA Clearance

Micronics, Inc. has announced today that its test for the detection of Shiga toxin-producing E. coli (STEC) has received clearance from the U.S. Food and Drug Administration.

June 4, 2018
·
1 min read
Deals

Bruker Acquires Sierra Sensors to Expand Real-Time, Label-Free Detection Portfolio for Pharma and Biopharma Drug Discovery

Bruker announced that it has acquired Sierra Sensors GmbH, based in Hamburg, Germany.

June 4, 2018
·
3 min read
Business

Virpax Pharmaceuticals Licenses Liposome Drug Delivery Technology From LipoCure

Virpax Pharmaceuticals (“Virpax”), signed a technology license agreement with LipoCure to develop pain management products.

June 4, 2018
·
2 min read
Pharm Country

Qosina Now Stocks Gamma-Stable, Large-Bore Tuohy Borst Adapters

Qosina is pleased to add tinted, gamma-sterilizable, large-bore tuohy borst adapters to its existing line of tuohy borsts. Qosina now carries 13 distinct, off-the-shelf options that can accommodate instrument sizes up to 18 FR.

June 4, 2018
·
1 min read
Drug Development

New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), today presented encouraging new data from a Phase 1 study evaluating ivosidenib (AG-120) or enasidenib (IDHIFA®; AG-221).

June 4, 2018
·
7 min read
BioMidwest

North Suburban Wellness Offers GAINSWave® in Illinois

North Suburban Wellness is pleased to announce they now offer GAINSWave!

June 4, 2018
·
2 min read
Job Trends

Calista Skin and Laser Center Offers GAINSWave® in Texas

Calista Skin and Laser Center is pleased to announce they now offer GAINSWave!

June 4, 2018
·
2 min read